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Familial	macular	degeneration	is	a	clinically	and	genetically	heterogeneous	group	of	disorders	characterized	by	
progressive	central	vision	loss.	Here	we	show	that	an	R373C	missense	mutation	in	the	prominin	1	gene	(PROM1)	
causes	3	forms	of	autosomal-dominant	macular	degeneration.	In	transgenic	mice	expressing	R373C	mutant	
human	PROM1,	both	mutant	and	endogenous	PROM1	were	found	throughout	the	layers	of	the	photoreceptors,	
rather	than	at	the	base	of	the	photoreceptor	outer	segments,	where	PROM1	is	normally	localized.	Moreover,	the	
outer	segment	disk	membranes	were	greatly	overgrown	and	misoriented,	indicating	defective	disk	morphogen-
esis.	Immunoprecipitation	studies	showed	that	PROM1	interacted	with	protocadherin	21	(PCDH21),	a	photore-
ceptor-specific	cadherin,	and	with	actin	filaments,	both	of	which	play	critical	roles	in	disk	membrane	morpho-
genesis.	Collectively,	our	results	identify	what	we	believe	to	be	a	novel	complex	involved	in	photoreceptor	disk	
morphogenesis	and	indicate	a	possible	role	for	PROM1	and	PCDH21	in	macular	degeneration.
Introduction
Retinal photoreceptor cells are highly specialized. One compart-
ment, organized as an outer segment (OS) in vertebrates, contains 
a stack of over 1,000 disks harboring rhodopsin and the photo-
transduction machinery. The entire OS is renewed by the continu-
ous formation of new disks at its base and the shedding of older 
disks from its distal end (1). In humans and most other primates, 
the region comprising about 20° in the center of the retina is 
known as the macula. Both rod and cone photoreceptor cells have 
regions of highest density in the macula, so that the macula pro-
vides high-acuity vision.
While genetically diverse and rare in prevalence, focus on famil-
ial macular degeneration has most often identified disease-causing 
gene mutations affecting photoreceptor and retinal pigment epi-
thelial (RPE) cell function (2–7). Previously, we mapped 2 inherited 
autosomal-dominant macular degeneration phenotypes to an over-
lapping region on chromosome 4p, a Stargardt-like macular dystro-
phy (Stargardt disease 4 [STGD4]; OMIM 603786; ref. 8) and bull’s-
eye macular dystrophy (MCDR2; OMIM 608051; ref. 9). STGD4 is 
characterized by bilateral, symmetric, atrophic lesions in the macula 
and by the presence of yellow fundus flecks, whereas MCDR2 is 
characterized by bilateral annular RPE atrophy at the macula (9).
In the present study, genetic screening and mutation analysis 
of the 12 genes residing within this overlapping disease interval 
revealed an R373C missense mutations in the prominin 1 gene 
(PROM1; GenBank accession no. AF027208, also known as CD133). 
PROM1 encodes a 5–transmembrane domain protein containing 2 
large, highly glycosylated extracellular loops and a cytoplasmic tail 
(10). It is specifically associated with plasma membrane protru-
sions (11, 12), but its function and specific molecular interactions 
remain largely unknown. It is present in many tissues. In the retina, 
PROM1 is found at the base of the photoreceptor OSs, where the 
new disk membranes are formed, and has previously been linked 
to autosomal-recessive retinal degeneration (13, 14).
In order to study the cellular basis for macular degeneration 
caused by mutant PROM1, as well as the molecular function of 
PROM1 in photoreceptor cells, we generated transgenic mice 
carrying the R373C mutant PROM1 and studied the ensuing 
pathogenesis. Additionally, we carried out molecular interac-
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tion studies with PROM1 to investigate its potential role in disk 
membrane morphogenesis.
Results
Identification of the PROM1 mutation in STGD4, MCDR2, and cone-
rod dystrophy pedigrees. Previously, we identified family pedigrees 
showing STGD4, clinically characterized by macular dystro-
phy and yellow fundus flecks (8), and an autosomal-dominant 
MCDR2, characterized by RPE atrophy (9) (Figure 1A and 
Supplemental Figure 1, A and B; supplemental material avail-
able online with this article; doi:10.1172/JCI35891DS1). In 
this study we narrowed the disease interval to a 12-cM region 
between markers D4S1582 and GATA1582G03. We screened 12 
candidate genes and identified a R373C missense mutation in 
PROM1 in both phenotypes (Figure 1B). We then identified the 
same R373C mutation in a third pedigree with an autosomal-
dominant cone-rod dystrophy characterized by both cone and 
rod photoreceptor degeneration (Supplemental Figure 1C). 
Comparison of disease haplotypes revealed that affected mem-
bers in the STGD4, MCDR2, and cone-rod dystrophy families 
had distinct disease haplotypes, indicating that the PROM1 
mutation in each family arose independently (Supplemental 
Figure 1). The logarithm of odds (LOD) score in each family was 
7.7, 2.1, and 4.4, respectively, and the combined LOD score of 
the 3 families was 14.2 at θ of 0 with marker D4S403. The muta-
tion segregated with affected individuals in each family (LOD 
score 5.8, 1.7, 4.3; combined LOD, 11.8 at θ of 0), and was absent 
in 400 normal matched controls. PROM1 was expressed in both 
cone and rod photoreceptors (Supplemental Figure 2).
Generation of transgenic mice expressing WT PROM1 and the R373C 
human PROM1 mutation. To gain insight into the molecular mecha-
nism of retinal degeneration caused by mutant PROM1, we gener-
ated transgenic mice carrying the R373C mutant human PROM1 
mutation under the control of the 4.4-kb rhodopsin promoter 
(15). Expression of the human PROM1 transgene in the retina 
was verified by Western blotting (Supplemental Figure 3A). As a 
control for overexpression of PROM1 in mice, we also generated 
transgenic mice expressing human WT PROM1. We characterized 
2 human WT (PWT20 and PWT31) and 2 mutant (PMT3 and 
PMT14) PROM1 transgenic mouse lines. By Western blot we found 
that the relative expression levels of WT (PWT20 and PWT31) and 
mutant (PMT14 and PMT3) human PROM1 transgenes were 1-, 
2-, 8-, and 2-fold, respectively, that of endogenous mouse Prom1 
expression (Supplemental Figure 3B).
WT and mutant PROM1 transgenic mouse phenotypes. Fundus images 
and light microscopy of retinal sections from transgenic mice 
expressing mutant PROM1 revealed progressive retinal abnormali-
ties visible as subretinal deposits and photoreceptor atrophy (Fig-
ure 1C and Supplemental Figure 4). Compared with PWT20 mice, 
PMT14 mice showed fundus changes characteristic of changes 
seen in humans with Stargardt disease. Yellow deposits and small 
lesions (Figure 1C, yellow arrows) were scattered throughout the 
Figure 1
Retinal degeneration as a consequence of mutant PROM1. (A and B) Clinical features of autosomal-dominant macular dystrophy and segrega-
tion of a PROM1 mutation. (A) Left: Fundus photograph from a STGD4 patient with visual acuity of 20/200, showing an area of macular atrophy 
with surrounding yellow flecks (white arrows). Right: Fundus photograph from an MCDR2 patient with a visual acuity of 20/80, showing bull’s-eye 
maculopathy (white arrows). (B) Sequencing traces demonstrating an 1117 C>T transition in exon 10 giving rise to the missense R373C substitu-
tion in both families. (C) Fundus photographs from representative 12-month-old PTW20 (left), 4-month-old PMT14 (middle), and 13-month-old 
PMT14 (right) mice. Yellow arrows denote yellow deposits and small lesions scattered throughout the central fundus. Black arrows denote large 
coalescing deposits and atrophic lesions in the fundus. (D) Progressive photoreceptor loss, as determined by the number of nuclei in the ONL, in 
PMT3 and PMT14 mice compared with normal C57BL/6 (control) and PWT20 mice. Photoreceptor cell nuclei were counted in transgenic mice 
between 4 and 40 weeks of age. Error bars, which in most cases are too small to be visible, represent ± SEM. The rate of photoreceptor cell loss 
was greater in the PMT14 line, which expressed higher levels of mutant PROM1 than did PMT3 mice (see Figure 3).
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central fundus in 4-month-old PMT14 mice. By 13 months of age, 
large coalescing deposits and atrophic lesions (Figure 1C, black 
arrows) covered much of the fundus. With fluorescein angiogra-
phy, the atrophic lesions showed hyperfluorescence at the earlier 
phase and hypofluorescence in the late phase, indicating a window 
defect and RPE atrophy (data not shown).
Mutant PROM1 transgenic mice exhibited progressive photore-
ceptor degeneration, measured by loss of photoreceptor nuclei in the 
outer nuclear layer (ONL; Figure 1D and Supplemental Figure 4). 
The rate of photoreceptor loss correlated with expression levels in 
the mutant PROM1 mouse lines, with 50% of photoreceptors lost 
from the regions located 200–300 μm dorsal and ventral to the 
optic nerve head at 4 weeks in PMT14 mice and 7 weeks in PMT3 
mice (Figure 1D). In contrast, higher levels of WT PROM1 trans-
gene expression did not cause retinal abnormalities or degenera-
tion (Figure 1D and Supplemental Figures 4 and 5).
Electron microscopy revealed that most of the rod photorecep-
tor OSs of mutant PROM1 retinas were disorganized. By 16 days 
after birth, during photoreceptor development, overgrown disk 
membranes were evident in PMT3 retinas (Figure 2A, arrows). By 
4 months of age, the remaining photoreceptors contained either 
vesiculated OS membranes (Figure 2B, arrowheads) or stacks of 
disk membranes that were of excessive size and aligned perpendic-
ular to normal disk orientation (Figure 2B, arrows and inset). The 
OSs of a WT retina are shown in Figure 2D. In the RPE, there were 
abnormal lipofuscin-like deposits (Figure 2C, arrows), indicating 
that this cell type was also compromised. Such deposits were not 
present in 4-month-old control (i.e., WT or PWT20) mice.
Electroretinography (ERG) recordings were performed to assess 
retinal function in PM14 mice (Supplemental Figure 5A). The rod 
and cone ERG b-waves were both significantly reduced relative to 
normal C57BL/6 controls (t test, 2.9; P < 0.01) and PWT20 mice 
(t test, 2.1; P < 0.05) at 3 months of age, indicating that both rod 
and cone photoreceptor cells are affected by mutant PROM1. 
B-wave responses were not detectable in the PM14 line at 9 months 
of age. Correspondingly, maximum high-intensity rod a-wave 
responses, which are proportional to the total number of func-
tioning photoreceptor disks, were reduced by an average of 50% 
at 3 months and were not detectable at 9 months of age (Supple-
mental Figure 5B).
WT and mutant PROM1 localization was examined by immuno-
histochemistry in transgenic and control mouse retinas. PROM1 
was previously observed by immunoelectron microscopy to be 
localized to the nascent disk membranes at the base of rod OSs in 
control retinas (13). Our immunofluorescence images were con-
sistent with this finding; label was restricted to a narrow region 
that corresponded to base of the photoreceptor OSs (Figure 
3, A–C). In PWT20 mice, PROM1 showed a similar localization 
pattern (Figure 3, D–F). Conversely, in PMT3 and PMT14 mice, 
mutant PROM1 was found most strongly in the myoid region 
of photoreceptors, a site containing predominantly ER, and 
throughout photoreceptors extending from OSs to the synaptic 
termini (Figure 3, G and J). The endogenous mouse Prom1 in these 
mutant retinas appeared to show mislocalization throughout the 
photoreceptor layers (Figure 3, H and K). Nevertheless, PROM1 
immunofluorescence should be interpreted with caution, because 
Western blot analysis showed low levels of PROM1 expression in 
PMT3 and PMT14 retinas (Supplemental Figure 3C).
Protocadherin 21 localization in PROM1 transgenic mice. Protocad-
herin 21 (PCDH21; GenBank accession no. AB053448), previously 
shown to also localize to the nascent disks at the base of the OSs, 
is thought to play a critical role in disk membrane morphogenesis 
(16). Based on its location similar to that of PROM1, we immuno-
labeled PCDH21 in WT and mutant PROM1 transgenic mice. In 
PWT20 mice, PCDH21 colocalized with WT PROM1 at the base 
of OSs (Figure 3, M–O). In mutant PROM1 retinas, PCDH21 was 
mislocalized in a pattern similar to that of PROM1 throughout 
photoreceptors (Figure 3, P–R). In contrast, immunolocalization 
of retinal OS membrane protein 1 (ROM1; found in the rims of the 
mature disk membranes; refs. 17, 18), rod cyclic nucleotide gated 
channel alpha subunit cook (CNGCA1; an OS marker; ref. 19), and 
Na+/K+-ATPase (an inner segment [IS] marker; ref. 20) proteins were 
not disturbed in mutant PROM1 mice (Supplemental Figure 6), 
indicating that mutant PROM1 does not have a generalized effect 
on intracellular vectorial or compartmental transport.
Based on these results, we also examined immunolocalization 
of the murine Prom1 in Pcdh21–/– mice. Pcdh21–/– mice were gen-
erated previously and were shown to form disorganized OSs and 
undergo photoreceptor degeneration (16). Using the mouse-
specific Prom1 antibody, we found WT Prom1 mislocalized 
throughout OSs in the absence of Pcdh21 (Figure 3, S–U). Simi-
lar to the mutant PROM1 transgenic mice, the Pcdh21–/– mice 
Figure 2
Electron microscopy of PROM1 transgenic mouse rod photorecep-
tors. (A and B) Overgrown and abnormally oriented disk membranes 
(arrows) in PMT3 retinas were visible at 16 days (A) and 4 months (B) 
of age. Arrowheads indicate vesiculated membrane. Higher-magnifi-
cation view of the boxed region in B is shown in the inset. (C) Elec-
tron micrograph showing abnormalities in the RPE of PMT3 mice at 
4 months of age. Accumulation of lipofuscin-like material (arrows) was 
evident. (D) Electron micrograph of a WT retina, showing normal OS 
disk membranes and adjacent RPE. Scale bars: 1 μm (A, B, and D); 
300 nm (C); 30 nm (B, inset).
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did not show perturbations in CNGCA1 (Figure 
3T) or Na+/K+-ATPase (Figure 3U) locations in the 
OS or IS photoreceptor regions, respectively. These 
results suggest that the interaction of these pro-
teins is required for normal Prom1 localization to 
the base of OSs and that this interaction plays a 
role in normal disk morphogenesis.
Physical interaction of PROM1 and PCDH21. Migra-
tion of WT PROM1 on SDS gel reflected the pre-
dominance of the glycosylated form (~114 kDa) 
when HEK293 cells were transfected with PROM1 
constructs (Figure 4A, lane 1). Infrequently, an addi-
tional faster-moving PROM1 polypeptide (~105 
kDa) was detected (Figure 4A, lane 3).
Because PCDH21 was mislocalized with mutant 
PROM1 in transgenic mice, we carried out coim-
munoprecipitation studies to determine whether 
PROM1 and PCDH21 directly interact. HEK293 cells 
were cotransfected with either WT or mutant PROM1 
and a PCDH21-Myc fusion construct. Interestingly, 
we found that WT and mutant PROM1 coimmuno-
precipitated with PCDH21 (Figure 4A, lanes 2 and 4). 
Reciprocally, PCDH21 coimmunoprecipitated with 
the human PROM1 antibody (Figure 4B, lanes 2 
and 3). To confirm their in vivo interaction, the 
PCDH21 antibody was used in immunoprecipitation 
reactions with WT and mutant PROM1 transgenic 
mouse retinal lysates. Western blot analysis showed 
the interaction of PCDH21 protein with WT and 
mutant PROM1 in vivo (Figure 4C).
Figure 3
Immunohistochemical localization of human PROM1 
and endogenous mouse PROM1 in PROM1 transgenic 
retinas at 1 month of age. (A–L) Localization of trans-
genic human PROM1 (red) and native mouse PROM1 
(green). (A–C) C57BL/6 mice showed endogenous 
mouse PROM1 signal alone at the base of the OSs. 
(D–F) In PWT20 mice, human PROM1 and endogenous 
mouse PROM1 were normally localized to the base of 
the OSs. (G–L) In PMT3 and PMT14 retinas, mutant 
PROM1 was mislocalized throughout the photoreceptors 
from the ONL to the OSs, whereas endogenous mouse 
PROM1 signal was more restricted to the ISs and OSs. 
Both endogenous mouse PROM1 and mutant PROM1 
showed strong immunolabeling in the myoid region 
of the ISs. (M–R) PROM1 (red) and PCDH21 (green) 
protein immunolocalization in WT and mutant PROM1 
transgenic retinas. (M–O) In 1-month-old PWT20 mice, 
PCDH21 and PROM1 colocalized at the base of pho-
toreceptor OSs. (P–R) In PMT14 mice, PCDH21 was 
mislocalized, as was PROM1, to the ONL. (S–U) WT 
PROM1 immunolocalization in Pcdh21–/– mice. WT 
PROM1 immunolabeling (S) was evident throughout 
OSs. PROM1 colocalized with the OS marker CNGCA1 
(T) and not the IS marker, Na/K-ATPase (U). Note that 
CNGCA1 and Na/K-ATPase signals were correctly 
located within OS and IS compartments, similar to the 
normal immunolabeling pattern in the R373C mutant 
PROM1 transgenic mice. INL, inner nuclear layer; OPL, 
outer plexiform layer; IPL, inner plexiform layer; GC, 
ganglion cells. Scale bars: 20 μm.
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PCDH21 undergoes proteolytic processing releasing the ectodo-
main and retaining the transmembrane and intracellular domains 
during disk morphogenesis (21). We observed an increase in levels 
of unprocessed, full-length PCDH21 (~125 kDa) and decreased 
levels of the cleaved fragment (~25 kDa) in cell lysates from 
mutant PROM1 mouse retinas compared with WT PROM1 trans-
genic and C57BL/6 retinas (Figure 4D). These results suggested 
that the R373C mutation may also affect proteolytic processing of 
PCDH21 in mutant PROM1 mice.
Physical interaction of PROM1 with actin. The overgrown and misori-
ented disk membranes in R373C PROM1 transgenic mice (Figure 
2, A and B) are strikingly similar to those previously observed in 
retinas treated with cytochalasin D in order to depolymerize actin 
filaments (22, 23). Hence, we explored whether there is an interac-
tion between PROM1 and actin filaments and whether any inter-
action would be affected by the R373C mutation. Cells transfected 
with WT PROM1 showed protrusions and membrane processes, 
and some of the PROM1 colocalized with actin, especially in the 
protrusions (Supplemental Figure 7). In contrast, cells transfected 
with mutant PROM1 did not possess protrusions, and the mutant 
PROM1 did not colocalize with actin (Supplemental Figure 7). We 
found a physical interaction between WT PROM1 and actin by 
immunoprecipitation in transfected cells (Figure 5) and in trans-
genic retinas (Supplemental Figure 8), and this interaction was 
markedly reduced by the R373C mutation (Figure 5). Furthermore, 
polymerization of actin filaments in photoreceptors was affected 
in mutant PROM1 transgenic mice compared with that in WT 
transgenic mice (Supplemental Figure 9). Taken together, these 
results indicate that PROM1 can interact with actin filaments and 
that this interaction is decreased by the R373C mutation.
Discussion
We report that a missense mutation in PROM1 causes 3 forms 
of autosomal-dominant retinal dystrophy. In transgenic mice 
expressing mutant PROM1, the mutant protein was mislocalized, 
and defects were evident in both rod and cone photoreceptor cells. 
ERG responses were reduced, and photoreceptor cell loss occurred 
at a rate that correlated with the expression level of the mutant 
PROM1. Most notably, the mutation in PROM1 interfered with 
its interaction with PCDH21 and actin, and prior to degenera-
tion, the disks of the photoreceptor OSs were aberrant. Both these 
observations support a role for PROM1 in the morphogenesis of 
new disk membranes.
PROM1 and retinal degeneration. Mutations in the PROM1 gene 
have been previously linked to pedigrees with autosomal-recessive 
retinitis pigmentosa (13, 14), where they mainly affect rod photo-
receptors and peripheral vision. These mutations were frameshift 
mutations, resulting in premature stop codons and truncation 
of the encoded protein, most likely representing null mutations. 
In transfection studies, the truncated protein was found to be 
degraded quickly; a minor amount was detected in the endoplas-
mic reticulum and it was absent from the cell surface, so that the 
degeneration in these patients appeared to have resulted from loss 
of PROM1 function (13). In contrast, the R373C mutation results 
in a stable mutant protein, and, as we show here, causes dominant 
macular degeneration that mainly affects cone photoreceptors and 
central vision. The R373C mutant PROM1 was mislocalized and 
caused the mislocalization of WT Prom1 as well as that of at least 
one other critical protein, PCDH21.
Interaction with PCDH21. Rattner et al. (16, 21) described a pho-
toreceptor cadherin, PCDH21; like PROM1, PCDH21 localizes to 
the nascent disks of rod and cone OSs. Moreover, like the PROM1 
R373C mutant mice, Pcdh21–/– mice exhibit disorganized photore-
ceptor membrane disks in OSs with corresponding photoreceptor 
degeneration (16). The present results support a functional inter-
action between PROM1 and PCDH21. PROM1 and PCDH21 were 
colocalized at the base of OSs, and PROM1 was coimmunoprecipi-
tated with full-length PCDH21. Further evidence of this interaction 
was obtained upon analysis of molecular abnormalities in R373C 
PROM1 transgenic mice. PCDH21 showed an overlapping mislo-
calized immunolabeling pattern with the R373C mutant protein in 
photoreceptors. With immunoblots, we found a marked reduction 
in cleaved PCDH21 levels in R373C mutant retinal lysates. Given 
that loss of PCDH21 results in retinal degeneration (16), the domi-
nant effect of the R373C PROM1 mutation on retinal degeneration 
could stem from impairment of PCDH21 function.
Because PROM1 and PCDH21 are both present on the nascent 
disks, their interaction appears likely to be within the same mem-
brane or between adjacent membranes of 2 nascent disks. In the 
latter case, they may play a role in maintaining the spacing between 
Figure 4
Coimmunoprecipitation of PROM1 and PCDH21 and proteolytic cleav-
age of PCDH21. (A) HEK293 cells were cotransfected with PCDH21 
and either WT or mutant PROM1. Immunoprecipitation was performed 
with anti-PCDH21, followed by anti-PROM1 immunodetection on 
a Western blot. Immunolabeling of WT (lane 1) and mutant (lane 3) 
PROM1 in the transfected cell lysates (anti-PROM1 Western blot) 
served as positive controls. Also shown is immunolabeling of WT (lane 2) 
and mutant (lane 4) PROM1 in the PCDH21 immunoprecipitates. (B) 
Reciprocal immunoprecipitation with PROM1 antibody after HEK293 
cells were cotransfected with PCDH21-Myc and WT (lane 2) or 
mutant (lane 3) PROM1. Lane 1 shows WT PCDH21-Myc–trans-
fected cell lysate (anti-Myc Western blot) as a positive control. (C) 
Immunoprecipitation of retinal lysates. Lysates from WT (lane 2) and 
mutant (lane 3) PROM1 transgenic mice were immunoprecipitated with 
anti-PCDH21, followed by anti-human PROM1 detection on a Western 
blot. Lane 1 is a PROM1 protein positive control, showing PROM1 
immunolabeling of retinal lysate. (A–C) Results of negative control 
experiments performed using nonspecific IgG were negative. (D) Pro-
teolytic processing of PCDH21 in PROM1 transgenic mice. Full-length 
(FL) and proteolytic C-terminal (CT) PCDH21 fragments were com-
pared among PMT3 (lane 1), C57BL/6 (lane 2), PWT31 (lane 3), and 
PWT20 (lane 4) mice. Total retinal protein lysate (20 μg) was probed 
with the PCDH21 C terminus antibody; β-actin was used as a loading 
control. PMT3 retinas showed substantially more full-length PCDH21 
and less cleaved fragment than did PWT20, PWT31 and C57BL/6 reti-
nas. Lanes were run on the same gel but were noncontiguous.
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neighboring disk membranes. Interestingly, Drosophila prominin is 
present on the tips of the rhabdomeral microvilli; together with 
the protein spacemaker, it is responsible for keeping the rhabdo-
meres apart, resulting in the formation of an open, rather than a 
closed, rhabdom (24).
Disk membrane morphogenesis. Steinberg et al. (25) proposed that 
the morphogenesis of disk membranes at the base of rod and 
cone OSs occurs by 2 membrane growth phases: the evagination 
of the ciliary plasma membrane followed by the formation of the 
disk rim. Although this model has gained experimental support 
over the years, Chuang et al. (26) recently revived another model, 
proposed by Obata and Usukura (27), in which vesicles fuse to 
form nascent disks that are assembled entirely within the cell’s 
plasma membrane. One of the weaknesses of this fusion model 
is the assumption that the nascent disks are closed and do not 
differ from the mature disks except in size. A variety of reports 
have shown that the nascent disks of rod OSs have several distinct 
characteristics. Unlike the more mature disks, the nascent disks 
can be labeled by Lucifer yellow administered to the extracellular 
space (28); they contain specific proteins, such as PCHD21 (16, 
21) and PROM1; and they specifically exclude some mature disk 
proteins, such as the rim protein peripherin/rds (29). Moreover, 
cone photoreceptor OSs, which in many species do not contain 
any closed disks, provide a clear demonstration of the presence of 
open disks (29–32). The membrane fusion presented in support of 
a fusion model (26) likely arises from a preservation artifact, along 
the lines described by Townes-Anderson (33).
In addition to its specific localization in nascent disks, previous 
data on PROM1 and our present results provide additional sup-
port to the evagination/rim growth model. PROM1 is best charac-
terized as a component of membrane domains that are protruding 
and have high curvature (10–12). Recently, PROM1 was detected at 
the tips of primary cilia on the neuroepithelium of the neocortex 
(34). Membrane was observed to bud off from these cilia (34), in 
a manner reminiscent of that from photoreceptor cilia in rds mice 
(35), which lack peripherin/rds (2) and are thus unable to form the 
rims of the disk membranes.
In the present study, we observed overgrown disk membranes, 
oriented abnormally along the OS plane, in R373C PROM1 trans-
genic mice (Figure 2, A and B). A strikingly similar phenotype has 
previously been described following the depolymerization of actin 
filaments with cytochalasin D in eyecup cultures and in retinas 
in vivo (22, 23). In these studies, observations of especially the 
cone disk membranes provided strong evidence that the over-
growth was caused by continued membrane evagination (23). 
The overgrown disks incorporated newly synthesized protein, and 
their formation appeared to result from a failure in the initia-
tion of new disk membranes — the initial protrusion of the ciliary 
plasma membrane was inhibited, so that the new membrane was 
channeled into nascent disks that were already growing (23). In 
addition to actin filaments, it seems likely that PROM1 is also 
required for the normal, regular initiation of new disks. This sug-
gestion is consistent with the general association of PROM1 on 
membrane protrusions (refs. 10–12 and Supplemental Figure 7), 
including those from primary cilia (34), and our present finding 
that PROM1 bound actin (Figure 5). Mice lacking RPGRIP, which 
interacts with the retinitis pigmentosa GTPase regulator (RPGR) 
in the photoreceptor connecting cilium, also produce overgrown 
disk membranes, and it has been suggested that RPGRIP may 
regulate actin cytoskeletal dynamics (36).
In summary, our results identify what we believe to be a novel 
molecular complex involved in photoreceptor disk membrane 
morphogenesis and support the model whereby new disk mem-
branes form by an evagination of the ciliary plasma membrane 
followed by rim growth.
Methods
Patients. Approval from the institutional review boards of the University 
of Utah, Moorfields Eye Hospital, and Institut de Recherche en Ophtal-
mologie was obtained for this study, and informed consent was obtained 
from all patients. Participating in the study were 27 individuals at risk for 
inheriting STGD4 in the first kindred, from the United States, a black fam-
ily; 9 individuals at risk for inheriting MCDR2 in the second kindred, from 
England, a family of mixed European descent; and 15 individuals at risk for 
inheriting cone-rod dystrophy in the third kindred, from Switzerland.
Genetic linkage and mutation screening. DNA was extracted from blood 
samples, and genetic linkage was assessed using microsatellite markers 
D4S1582, D4S2906, D4S403, D4S2362, GGAT18G02, D4S1525, D4S2946, 
D4S2633, D4S2926, and GATA158G03 (tightly linked to the STGD4 and 
MCDR2 loci) using previously established methods (6). We performed 
2-point linkage analysis using the FASTLINK (37) version of MLINK from 
the LINKAGE Program Package (38). An autosomal-dominant mode of 
inheritance with full penetrance was used for LOD score computation. 
Disease allele frequency was set at 0.0001 (39). PROM1 mutation screening 
was performed by denaturing HPLC (dHPLC) analysis followed by direct 
sequencing of PCR-amplified DNA fragments for all 23 PROM1 exons 
using previously established methods (6). PCR primers were designed to 
include flanking intronic sequences of each exon according to published 
protocols (6). Amplified products were purified using the QIAquik Gel 
Extraction Kit (Qiagen) and sequenced with forward and reverse primers 
by the Taq Dyedeoxy Terminator Cycle Sequencing Kit (Beckman-Coul-
ter) according to the manufacturer’s instructions. dHPLC analysis was 
used according to the manufacturer’s instructions (Transgenomics Inc.) 
Figure 5
Coimmunoprecipitation of PROM1 and β-actin. (A) HEK293 cells 
were transfected with either WT or mutant (MT) PROM1. Whole 
cell lysates with equal amounts of input WT or mutant PROM1 were 
immunoprecipitated with PROM1 polyclonal antibody, followed by anti–
β-actin immunodetection on Western blots (WB). (B) Quantification of 
PROM1 and β-actin interaction by densitometry. Values (mean ± SD) 
denote the amount of β-actin, immunoprecipitated with PROM1 antibod-
ies from cells, transfected with WT or mutant PROM1. Each experiment 
was done in triplicate, and 3 independent transfection experiments were 
performed for each PROM1 construct. Significance was examined using 
independent sample t test.
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to screen for changes in PROM1 sequence and to determine the presence or 
absence of the mutation in the controls.
Generation of expression constructs. Forward and reverse primers (5′-
CCGCTCGAGCGTTGCTAGCTATGGCCCTC-3′ and 5′-ATAGTTTAGC-
GGCCGCATTCTTATTCAATGTTGTGATGGGCTTGTC-3′, respectively) 
containing Xhol and Notl restriction sites were designed for amplification of 
WT human PROM1 cDNA. Following Xhol and Notl restriction digest, the 
amplified cDNA was cloned into the Xhol and Notl sites of the pcDNA3.1(–) 
vector (Invitrogen). The 1117 C>T (R373C) mutation was introduced into 
the WT PROM1 pcDNA3 construct by PCR-based site-directed mutagen-
esis. The recombinant plasmids were purified using a Qiagen plasmid iso-
lation kit (Qiagen). Mouse PCDH21 expression constructs were generously 
provided by A. Rattner and J. Nathans (Johns Hopkins University School of 
Medicine, Baltimore, Maryland, USA; ref. 21). All constructs were verified 
by restriction digestion and DNA sequencing.
Generation of PROM1 transgenic mice. WT or mutant human PROM1 
cDNAs, generated as described above, were subcloned into the pRHO4.4 
plasmid, containing the 4.4-kb human rhodopsin promoter — directing 
expression to rod and cone photoreceptors (15) — and a bovine poly A site. 
All constructs were verified by restriction enzyme digestion and direct DNA 
sequencing. Inserts were isolated by Notl and Kpnl digestion, microinjected 
into C57BL/6 mouse embryos, and implanted into pseudopregnant foster 
female mice. Founder mice were identified by PCR. Human PROM1 prim-
ers (forward, 5′-CCGCTCGAGCGTTGCTAGCTATGGCCCTC-3′; reverse, 
5′-CGGGATCCCGCTATCAATGTTGTGATGGGC-3′) were used for PCR 
analysis of genomic DNA extracted from mouse tail biopsies. WT and 
mutant transgenic lines were established and propagated in the C57BL/6 
mouse strain. All procedures were approved by the IACUC of the University 
of Utah and carried out according to NIH guidelines.
PROM1 expression in transgenic mice. After removal of the lens, retinas from 
1-month-old mice were manually separated from the RPE and lysed in 150 
mM NaCl; 50 mM Tris, pH 7.5; 1 mM EDTA; 1% Triton X-100; 0.5% SDS; 
and protease inhibitor mixture (Roche Applied Science). Protein from each 
retinal lysate (10 μg) was separated by SDS-PAGE, transferred to PVDF 
filters, and probed with either human PROM1– or mouse Prom1–specific 
antibodies, followed by incubation with HRP-conjugated secondary anti-
bodies and standard ECL detection.
Fundus photography and fluorescein angiography. Fundus photographs and 
fluorescein angiographs for C57BL/6 and WT and mutant PROM1 trans-
genic mice were recorded at 6 and 9 months of age using a Kowa RC-2 hand-
held fundus camera (Kowa Genesis). The eyes were dilated with scopolamine 
(0.25%; Isopto Hyoscine; Alcon) 1 h prior to photography. Fluorescein angio-
graphs were recorded with negative black and white film after intraperitoneal 
injection of 0.2 ml 25% sodium fluorescein diluted 1:1 with sterile PBS.
Histology and light microscopy. Mice were maintained in a continuous 12-h 
light/12-h dark cycle and sacrificed 8–12 h after the onset of the light 
phase. Anesthetized mice were perfused with 0.1 M PBS and then with 2.5% 
glutaraldehyde in 0.1 M PBS (pH 7.4) by intracardiac injection. The supe-
rior sclera of each eye was marked for orientation. Eyecups were processed 
for embedding in Epon. Sections of 0.5 μm, oriented along the dorsoven-
tral axis of the retina and containing the optic nerve head, were used for 
measuring photoreceptor ONL width. Photoreceptor nuclear counts were 
measured within 200–300 μm dorsal and ventral regions flanking the optic 
nerve head. Five separate counts per side (total 10 counts) were averaged, 
and ONL width was expressed as average number of nuclei.
Dark-adapted ERG. Electroretinograms were obtained from 42 mice 
between the ages of 3 and 15 months: 19 PMT14, 8 PWT20, and 15 
C57BL/6. Several mice were tested at more than one age. Mice were dilated 
with 0.25% scopolamine, dark-adapted overnight, and prepared for record-
ing under a dim red light while the dilation was reinforced with scopol-
amine. Mice were anesthetized with intraperitoneal injection of 0.008 
ml/g of a mixture of ketamine (20%), xylazine (0.5%), and sodium chloride 
solution (79.5%). The corneal electrode was a Burian-Allen mouse electrode 
referenced to a needle electrode in the scalp. A second needle electrode in 
the tail served as ground. Mice were placed between 2 heating pads to sta-
bilize body temperature, which was continuously monitored with a digital 
probe. The eye was numbed with proparacaine hydrochloride (Alcaine; 
Alcon) and Refresh Celluvisc (Allergan Inc.) was added to the contact lens 
electrode to protect the eye. Signals were amplified 10,000× and filtered 
(8-pole Butterworth 60-Hz notch filter) to remove line noise before averag-
ing (n = 20–200) by computer. A ganzfeld dome and the incorporated Grass 
photostimulator, similar to systems used in human testing, was used to 
produce flashes comparable to the International Society for the Clinical 
Electrophysiology of Vision standard (40). Rod a-waves were elicited by a 
high-intensity Xenon flash (Novatron). The rod phototransduction model 
was fit to the leading edges of a-waves generated in response to high-inten-
sity stimuli, and the dashed curves were the best fitting curves (41). Cone 
b-wave responses were obtained in the presence of a rod-saturating back-
ground (3.2 log photopic trolands).
Electron microscopy. Eyes from WT and mutant PROM1 transgenic mice 
were fixed in 2% paraformaldehyde plus 2% glutaraldehyde in 0.1 M caco-
dylate buffer, pH 7.4, and embedded in Epon 812 resin. Ultrathin sections 
were mounted on copper grids and stained with uranyl acetate and lead 
citrate and examined with a Philips electron microscope (model 208).
Immunohistochemistry. Antibodies used in these studies included rabbit 
polyclonal anti-human PROM1 (42); rat monoclonal anti-mouse Prom1 
(11); rabbit polyclonal anti-mouse PCDH21 (diluted 1:500; gift from A. 
Rattner and J. Nathans; ref. 16); mouse monoclonal anti-mouse CNGCA1 
(diluted 1:100; gift from R. Molday, University of British Columbia, Van-
couver, British Columbia, Canada; ref. 19); mouse monoclonal anti-mouse 
ROM1 (diluted 1:100; gift from R. Molday; ref. 43); and rabbit polyclonal 
anti-mouse Na+/K+-ATPase (diluted 1:100; obtained from the Develop-
mental Studies Hybridoma Bank, University of Iowa).
Cryostat sections (12 μm) were washed with 1× PBS, blocked in immuno-
histochemical buffer (0.2% Triton X-100 in PBS) containing 10% goat 
serum at room temperature for 1 h. Sections were incubated in primary 
antibody overnight at 4°C. After washing, sections were incubated in FITC-
conjugated goat anti-rabbit or Texas Red–conjugated goat anti-mouse sec-
ondary antibodies (diluted 1:100; Invitrogen) at room temperature for 1 h. 
Immunofluorescence was examined, and images were captured on a Zeiss 
510 confocal microscope.
Cell transfection and immunoprecipitation reactions of PROM1 and PCDH21. 
Cultured cells were propagated in DMEM (Gibco; Invitrogen) supple-
mented with 10% FBS (Gibco; Invitrogen), 100 U/ml penicillin, and 100 
μg/ml streptomycin. Cells were transfected with recombinant human 
WT or mutant PROM1 and mouse recombinant PCDH21 (containing a 
C-terminal Myc epitope tag) with FuGENE 6 Transfection Reagent (Roche 
Applied Science) according to the manufacturer’s recommended protocol. 
At 36 h after transfection, cells were lysed in 150 mM NaCl; 50 mM Tris, 
pH 7.5; 1 mM EDTA; 1% Triton X-100; 0.5% SDS; and a protease inhibitor 
mixture (Roche Applied Science). Cell lysates were centrifuged at 1,600 g 
for 5 min at 4°C to remove nuclei and insoluble material. The anti-PROM1 
antibody was used to immunoprecipitate PROM1-binding proteins. The 
immunoprecipitated proteins were separated by SDS-PAGE, transferred 
to PVDF filters, and probed with the Myc antibody on Western blot. The 
reciprocal experiment was performed using the PCDH21 antibody for 
immunoprecipitations followed by Western blot with anti-PROM1. For 
retinal coimmunoprecipitation studies, retinas were isolated and pooled 
from 10 WT or mutant PROM1 transgenic mice, and protein was extracted 
as described above.
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Western blots of PROM1 and PCDH21 in transgenic mouse retinas. Dissected 
retinas were briefly homogenized in buffer containing 150 mM NaCl; 50 
mM Tris, pH 7.5; 1 mM EDTA; 1% Triton X-100; 0.5% SDS; and complete 
protease inhibitor mixture (Roche Applied Science). Following a 20-min 
incubation on ice, lysate was cleared of nuclei and insoluble material by 
centrifugation at 1,600 g for 5 min at 4°C. Soluble proteins were sepa-
rated by SDS-PAGE, after which Western blot analysis was performed. 
The polyclonal PCDH21 C-terminal antibody was used to detect full-
length PCDH21 and the C-terminal proteolytic fragment in C57BL/6 and 
PROM1 transgenic mice. A polyclonal antibody specific for human PROM1 
without cross-reactivity to the mouse Prom1 was used to detect WT and 
mutant PROM1 transgene expression. An anti-mouse β-actin antibody 
(Sigma-Aldrich) was used as a loading control. For visualization, blots 
were probed with a HRP-conjugated anti-rabbit or anti-mouse secondary 
antibody (diluted 1:4,000; GE Healthcare) and developed with an ECL kit 
according to the manufacturers’ protocol (GE Healthcare).
Immunoprecipitation of PROM1 and actin. HEK293 cells transfected with WT 
or mutant PROM1 were lysed in the wash buffer (50 mM Tris, pH 7.5; 150 
mM NaCl; 1% NP-40; and 0.5% sodium deoxycholate) supplemented with 
complete protease inhibitors (Roche Applied Science), centrifuged at 10,000 g 
for 5 min to obtain postnuclear supernatant, and immunoprecipitated using 
affinity-purified polyclonal PROM1 antibodies. Immunocomplexes were 
precipitated by Protein A-Agarose (Pierce Biotechnologies Inc.) and washed 
4 times with wash buffer. Immunoprecipitated protein samples were eluted 
with Laemmli buffer with 100 mM DTT, resolved by 10% SDS-PAGE, and 
immunoblotted with β-actin monoclonal antibodies (Sigma-Aldrich).
Dissected retinas from 1-month-old PWT20 mice were homogenized in 
buffer containing 150 mM NaCl; 50 mM Tris, pH 7.5; 1 mM EDTA; 1% 
Triton X-100; 0.5% SDS; and complete protease inhibitor mixture (Roche 
Applied Science). Lysate was centrifuged at 10,000 g for 5 min to obtain 
postnuclear supernatant and then immunoprecipitated using affinity-puri-
fied polyclonal PROM1 antibody. Immunocomplexes were precipitated 
by Protein A-Agarose, resolved by 10% SDS-PAGE, and immunoblotted 
with a β-actin monoclonal antibody.
Immunostaining and fluorescence microscopy of PROM1 and actin. HEK293 
cells were transfected with WT or mutant PROM1. Immunostaining was 
performed essentially as described previously (44). Slides were incubated 
for 1 h at room temperature in anti-PROM1 (diluted 1:500) or rhodamine-
conjugated phalloidin for F-actin (diluted 1:2,000). Laser-scanning confo-
cal microscopy was performed on a Zeiss LSM510 microscope with kryp-
ton-argon and helium-neon lasers.
Cryosections of PWT20 and PM3 retinas were labeled with FITC-conju-
gated phalloidin (Invitrogen) to visualize actin filaments and with tubulin 
antibody. Immunofluorescence was examined, and images were captured 
on a Zeiss 510 confocal microscope.
Statistics. Significance of differences was determined using SPSS software. 
Comparisons were made by 2-tailed Student’s t test. A P value less than 
0.05 was considered significant.
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